Suchergebnisse - "Perrone, Francesco"

PubPharm (18)

1

Biological and clinical impact of membrane EGFR expression in a subgroup of OC patients from the phase IV ovarian cancer MITO-16A/MANGO-OV2A trial

enthalten in: Journal of experimental & clinical cancer research : CR | 2023

von Forlani, L. | De Cecco, L. | Simeon, V. | +21

2

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC : The BEVERLY Multicenter Randomized Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Piccirillo, M. | Bonanno, L. | Garassino, M. | +30

3

cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors : Time for clinical implementation?

enthalten in: EBioMedicine | 2020

von Normanno, N. | De Luca, A. | Perrone, F.

CommentOn: EBioMedicine. 2020 Jul;57:102861. - PMID 32629391

4

BEVERLY : Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer

enthalten in: Clinical lung cancer | 2016

von Gridelli, C. | Rossi, A. | Ciardiello, F. | +10

5

Afatinib : An overview of its clinical development in non-small-cell lung cancer and other tumors

enthalten in: Critical reviews in oncology/hematology | 2016

von Giordano, P. | Manzo, A. | Montanino, A. | +10

6

Treatment of Elderly Patients With Non-Small-Cell Lung Cancer : Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

enthalten in: Clinical lung cancer | 2015

von Gridelli, C. | Balducci, L. | Ciardiello, F. | +7

CommentIn: Clin Lung Cancer. 2016 Mar;17(2):e25-7. - PMID 26700909

7

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26) : a double-blind, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2014

von Ellis, P. | Shepherd, F. | Millward, M. | +24

CommentIn: Lancet Oncol. 2014 Nov;15(12):1289-90. - PMID 25439684

8

Combining anti-Epidermal Growth Factor Receptor (EGFR) and anti-angiogenic strategies in advanced NSCLC : we should have known better…

enthalten in: Current pharmaceutical design | 2014

von Di Maio, M. | Morabito, A. | Piccirillo, M. | +7

9

Advanced non-small-cell lung cancer with epidermal growth factor receptor mutations : current evidence and future perspectives

enthalten in: Expert review of anticancer therapy | 2013

von Costanzo, R. | Montanino, A. | Di Maio, M. | +9

10

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer : the TORCH randomized trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Gridelli, C. | Ciardiello, F. | Gallo, C. | +25

CommentIn: J Clin Oncol. 2013 Jan 10;31(2):288-9. - PMID 23233717